The NOW Corporation to Receive $5,000,000 Capital Injection

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
The NOW Corporation to Receive $5,000,000 Capital Injection

PORTLAND, OR --(Marketwired - December 16, 2015) - THE NOW CORPORATION ( OTC PINK : NWPN ) announced today that it has entered into an Equity Purchase Agreement with Red River Ventures, LLC, a Texas limited liability company. As part of the negotiated deal terms, The NOW Corporation will receive a capital injection of $5,000,000 in order to begin construction on its first Colorado-based hydroponic facility.

Furthermore, as part of the negotiations, The NOW Corporation will receive $5,000,000 upon filing an S-1 Registration Statement with the Security and Exchange Commission, which is expected to take place within the next 75 days. As a result, The NOW Corporation's management team expects to begin construction of its first hydroponic facility in the first quarter of 2016.

To continue, the facility will be used to grow industrial hemp in a controlled environment in order to ensure ideal growth conditions and maximum number of harvests throughout the year. Additionally, each acre is estimated to grow 28,800 hemp plants with an expected 5 grams of CBD's per plant at an expected market value minimum of $25 per gram with three to four harvests per year (28,800 plants x 5 grams @ $25 x 3 to 4 harvests per year). All of which potentially represents over $12,000,000 in projected gross revenues to the company.

Also, The NOW Corporation's management team will be working on enhancements to its hydroponic facility in order to grow between 57,600-86,400 plants -- increasing revenue per harvest per acre. This would increase the projected revenues by three to four times.

About The NOW Corporation

The NOW Corporation's core mission is to profitably utilize new and existing properties where legalized growing of industrial hemp is allowed. This will take place during the inevitable transition of the country's new laws wherein we will establish the company as a leader in the industrial hemp revolution. For more information about The NOW Corporation, please visit us at: www.thenowcorporation.net

Certain statements in this news release constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward-looking information" All forward-looking statements are based on The Now Corporation's current expectations, estimates, projections, beliefs and assumptions based on information available at the time the statement was made and in light of The Now Corporation's experience and its perception of historical trends.

CONTACT:  NOW Corporation: 800-997-8477 www.thenowcorporation.net

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Maxpro Capital Stock Faces Tough Times, Drops to New Lows

Updated Category News Views 87

Maxpro Capital Acquisition Corp. Hits 52-Week Low The current climate in the investment market has led to notable challenges, and Maxpro Capital Acquisition Corp. (APLM) is feeling the strain. With shares dropping to $8.01, the stock has reached a concerning 52-week low. This decline represents a staggering 92.63% decrease over the past year, causing investors to reassess...

Continue Reading
Investors Urged to Join Class Actions Against FLYW, LMT, SOC

Updated Category News Views 133

Important Deadline for Investors in FLYW, LMT, and SOC The Law Offices of Howard G. Smith are highlighting opportunities for investors to engage in class action lawsuits regarding potential securities fraud involving several notable companies, including Flywire Corporation (NASDAQ: FLYW), Lockheed Martin Corporation (NYSE: LMT), and Sable Offshore Corp (NYSE: SOC). For...

Continue Reading
Labcorp's Strong Performance: Q4 2024 and 2025 Outlook

Updated Category News Views 443

Labcorp's Financial Highlights for Q4 2024 Labcorp Holdings Inc. (NYSE: LH), a renowned provider of comprehensive laboratory services, recently released its financial results for the fourth quarter of 2024. The company achieved substantial growth in several key performance areas, reflecting its strategic initiatives in diagnostics and biopharma services. Revenue and...

Continue Reading
In-Depth Analysis of Regeneron Pharmaceuticals' Options Market Trends

Updated Category News Views 204

Insights Into Regeneron Pharmaceuticals' Options Market Recently, there has been a noticeable bullish sentiment among significant investors regarding Regeneron Pharmaceuticals. Investors with substantial resources are making their presence felt in the options market, indicating confidence in the company's future prospects. Upon examining the options trading history for...

Continue Reading
Ant Group Secures $6.5 Billion Credit Line Refinancing Deal

Updated Category News Views 96

Ant Group's Significant Credit Line Refinancing Ant Group, a key player in the fintech sector and closely linked with Alibaba, has revealed plans to refinance a massive credit line amounting to $6.5 billion. This move underscores the company's ongoing financial strategies, particularly under the leadership of its founder, Jack Ma. Refinancing Details This refinancing...

Continue Reading